MIMOSA Diagnostics
PrivateLast Round
VC Round
Jun 10, 2024
Total Funding Raised
$168,000
Company Overview
MIMOSA Diagnostics is a medical device company that has developed a handheld, multispectral skin tissue imaging device and data platform for early and accurate diagnosis of a wide range of skin tissue injuries.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Healthcare Analytics, Telemedicine
Business Model
B2B
Customer Profile
Hardware + Subscription, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MIMOSA Diagnostics Comparables
Compare MIMOSA Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kent Imaging | 87% | |
| WoundVision | 85% | |
| Swift Medical | 84% |
MIMOSA Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 10, 2024 | ||||
| Grant | Mar 27, 2024 | ||||
| Convertible Debt | Jul 17, 2023 | ||||
| Grant | Dec 20, 2020 | ||||
| Seed | May 6, 2020 | ||||
Grant | Apr 1, 2020 |
Key People
Founding team and executive leadership
MIMOSA Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Maple Leaf Angels | Seed |
| Kindling Investment Partners | VC Round |
| Tidal Venture Partners | Convertible Debt |
| BDC Capital | Seed |
| National Research Council Canada | Grant |
| Kern Venture Group | VC Round |
| MEDTEQ+ | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 17, 2023
Raised funding from Tidal Venture Partners, XDL Capital Group, and Ontario Centre of Innovation.
- May 6, 2020
Raised capital from BDC Capital, Maple Leaf Angels, and MEDTEQ+.
MIMOSA Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about MIMOSA Diagnostics's valuation, stock price, and market status.
Is MIMOSA Diagnostics a public or private company?
MIMOSA Diagnostics is a private company.
What is the current stock price of MIMOSA Diagnostics?
MIMOSA Diagnostics is a private company with no public stock price. No recent secondary market data is available.
How much is MIMOSA Diagnostics worth (valuation)?
Valuation information for MIMOSA Diagnostics is not publicly available.
Can I buy MIMOSA Diagnostics stock?
MIMOSA Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was MIMOSA Diagnostics's last funding round?
MIMOSA Diagnostics's most recent funding round was VC Round on June 10, 2024.
Who are the main investors in MIMOSA Diagnostics?
Key investors in MIMOSA Diagnostics include Kindling Investment Partners, Tidal Venture Partners, Kern Venture Group, Spring.
Will MIMOSA Diagnostics IPO soon?
No public IPO plans have been announced for MIMOSA Diagnostics.
How can I track MIMOSA Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor MIMOSA Diagnostics's secondary market activity and sign up for updates.